HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Profit After Tax (2015 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Profit After Tax came in at -$198.9 million in Q4 2021, down 251.6% quarter-over-quarter from $131.2 million in Q3 2021.

Analysis

HUTCHMED (China) (HMDCF) Profit After Tax (2015 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Profit After Tax for 6 consecutive years, with -$198.9 million the latest figure, recorded in Q4 2021.

  • On a quarterly basis, Profit After Tax changed N/A year-over-year to -$198.9 million in Q4 2021; TTM through Dec 2021 was -$167.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $456.9 million, up 1111.03% from the prior year.
  • Profit After Tax was -$198.9 million for Q4 2021 at HUTCHMED (China), down from $131.2 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $180.7 million in Q4 2019 and troughed at -$198.9 million in Q4 2021.
  • A 4-year average of -$2.7 million and a median of -$12.9 million in 2018 frame the typical range for Profit After Tax.
  • The widest YoY moves for Profit After Tax: up 1047.54% in 2019, down 254.36% in 2019.
  • Over 4 years, Profit After Tax stood at $15.7 million in 2018, then soared by 1047.54% to $180.7 million in 2019, then sank by 118.16% to -$32.8 million in 2020, then slumped by 506.08% to -$198.9 million in 2021.
  • The last three Profit After Tax figures came in at -$198.9 million (Q4 2021), $131.2 million (Q3 2021), and -$59.5 million (Q2 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 211.88 Bn 197.89 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 181.55 Bn 178.37 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 132.31 Bn 124.45 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 61.54 Bn 56.36 Bn 1.37 Bn 472.00 Mn
6 Moderna 54.69 Bn 49.55 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 34.07 Bn 30.76 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.41 Bn 30.12 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn -290.61 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -198.92 Mn
Sep 28, 2021 131.22 Mn
Jun 30, 2021 -59.49 Mn
Mar 31, 2021 -39.85 Mn
Jun 30, 2020 -32.82 Mn
Mar 31, 2020 -15.43 Mn
Dec 31, 2019 180.72 Mn
Sep 30, 2019 -31.24 Mn
Jun 30, 2019 -62.56 Mn
Mar 31, 2019 19.11 Mn
Dec 31, 2018 15.75 Mn
Sep 30, 2018 25.41 Mn
Jun 30, 2018 40.53 Mn
Mar 31, 2018 -10.41 Mn
Jun 30, 2016 29.56 Mn
Jun 30, 2015 23.49 Mn